AMPY vs REPX: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
REPX is the larger of the two ($912.29M market cap): the incumbent the market prices for continued execution (3.45x forward earnings, beta 0.91). AMPY is the smaller challenger ($155.01M), actually pricier on forward earnings (4.61x): more room to run, but more to prove. On the numbers, REPX leads on both counts: faster expected revenue growth (22% vs 12%) and a lower forward P/E (3.45x vs 4.61x). The case for AMPY rests on its own driver (Beta drilling in the Joulters fault block): if you believe in that, AMPY fits; if you believe in what the numbers show today, REPX does.
AMPY vs REPX: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | AMPY | REPX | What it tells you |
|---|---|---|---|
| Market cap | $155.01M | $912.29M | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 4.61 | 3.45 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 6.68 | 8.72 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.25 | 0.91 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 20% of range | 56% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 0.38 | 1.46 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: REPX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how AMPY and REPX affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AMPY and REPX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AMPY and REPX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Amplify Energy (AMPY) do?
Amplify Energy Corp. is a Houston-based independent oil producer listed on the NYSE. Until late 2025 it ran a mixed portfolio spanning East Texas and Louisiana gas, Oklahoma, the Eagle Ford and two oil assets. Over 2025 it closed six transactions worth about $250M, including the $122M East Texas sale and the $92.5M Oklahoma sale in December, and used the proceeds to repay its entire credit facility. What remains is Beta, a set of platforms in federal waters off Huntington Beach, California, and Bairoil, a carbon dioxide enhanced oil recovery (EOR) unit in Wyoming. Production is now ~7.4 thousand barrels a day and 100% oil (Q3 2026), down from ~18.4 MBoe/d across the old portfolio in 2025.
What does Riley Exploration Permian (REPX) do?
Riley Exploration Permian, Inc. is an independent oil and gas producer based in Oklahoma City that drills and operates wells in two parts of the Permian Basin. Its Texas assets sit on the Northwest Shelf in Yoakum County, where it has worked the San Andres formation for years. Its New Mexico position, the Red Lake area in Eddy County, came largely from the 2023 Pecos Oil & Gas purchase and grew again with the Silverback Exploration II acquisition on July 1, 2025. About 60% of its output is oil, which is why its revenue tracks West Texas crude much more than natural gas. The company also holds a stake in RPC Power, a joint venture focused on power generation.
AMPY vs REPX: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- AMPY drivers: Beta drilling in the Joulters fault block; Royalty relief and lower operating costs.
- REPX drivers: Production growth from a drilling backlog; New Mexico infrastructure coming online.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Amplify is now a two-asset company, so a single operational problem can swing results. For REPX, oil price is the dominant risk.
AMPY or REPX: which should you pick?
If the story you believe is AMPY's (Beta drilling in the Joulters fault block), AMPY is the more direct way to own it; if it is REPX's (Production growth from a drilling backlog), REPX is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AMPY and REPX guides.
AMPY vs REPX: the full fundamentals
AMPY. Headline multiples flatter and confuse in equal measure. The trailing P/E of ~6.6 rests on gains from asset sales and derivatives, and trailing revenue of ~$198M still includes December 2025 output from East Texas and Oklahoma; the continuing business generated ~$141M of revenue in the first nine months of 2026. With no revolver debt and ~$10M of cash at September 30, enterprise value is roughly ~$150M, or about 4x to 5x guided 2026 EBITDA, and the market cap is well under half of proved PV-10. Adding ~$72M of retirement obligations narrows that gap. The two-analyst consensus target sits near ~$7.75.
REPX. Trailing revenue of about $578 million combines the first nine months of 2026 ($481 million) with Q4 2025 (about $97 million). GAAP net income is distorted by hedge accounting, swinging from a $70 million loss in Q1 2026 to an $87 million profit in Q2, so a trailing GAAP price-to-earnings ratio near 8.7x says little. The forward multiple of about 3.5x rests on analysts' 2027 EPS estimate of about $11.94, which assumes oil stays firm and volumes keep rising. Adjusted figures are steadier: Q3 adjusted EPS was $2.66, and adjusted EBITDAX ran about $117 million for the quarter. On roughly 22.15 million shares and $245 million of debt, enterprise value is about $1.15 billion, which is low relative to cash flow if oil holds near $90 and high if it falls back toward $60.
Headline figures (approximate, November 2026): AMPY shows share price (nov. 20, 2026) $3.84, market cap ~$154M, revenue (ttm) ~$198M (includes assets sold in Dec 2025), net income (ttm) ~$22M (swung by hedge marks and asset-sale gains); REPX shows share price (nov 20, 2026) ~$41, market cap ~$0.9 billion, revenue (ttm) ~$578 million (Q3 up ~88% yoy), operating margin (ttm) ~46%.
The bottom line: AMPY vs REPX
AMPY and REPX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined AMPY and REPX exposure against your real portfolio. It is not an investment adviser.
Wondering how AMPY or REPX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Amplify Energy
Ask Walnut's AI anything about AMPY and see how it fits what you own.
FAQ
What is the difference between AMPY and REPX?
+
Amplify Energy Corp. Riley Exploration Permian, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is AMPY or REPX the better stock?
+
Neither is universally better. REPX is the larger incumbent; AMPY is the smaller challenger and looks pricier on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, AMPY or REPX?
+
On forward P/E (as of November 2026), AMPY trades at 4.61x and REPX at 3.45x, so REPX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both AMPY and REPX?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of AMPY vs REPX?
+
AMPY: Amplify is now a two-asset company, so a single operational problem can swing results. Beta runs on platforms installed decades ago and a pipeline to shore; in October 2021 that pipeline leaked ~25,000 gallons of crude off Huntington Beach, shutting the field until 2023 and producing criminal and civil settlements. Another incident would carry heavy financial and reputational cost, and California remains hostile to offshore oil, with permitting, litigation and political risk well above Texas norms. Decommissioning obligations are large: asset retirement obligations were ~$72M at year end 2025 and the company funds a Beta sinking fund of ~$9M a year. Free cash flow was negative in the first half of 2026 and only ~$2.0M in Q3, and liquidity was a modest ~$25M at September 30 (~$10M of cash plus ~$15M of revolver capacity), with a borrowing base redetermination underway. Hedges mean a price spike helps less than the headline suggests, and swings in their mark-to-market value drive large GAAP losses, as Q3's ~$24.6M unrealized loss showed; a price collapse after Middle East supply normalizes would hurt high-cost barrels quickly. Pump failures cut Beta output in the first half. Analyst coverage is thin, trading volume is light, and the 2025 Juniper merger that was announced and then terminated shows how strategic plans here can change abruptly. REPX: Oil price is the dominant risk. About 60% of production is crude, and the stock fell from about $53 to about $41 in the first week of November 2026 as WTI dropped from roughly $104 to near $90. A further fall would cut cash flow directly, although hedges soften the first part of the hit. Those same hedges are a risk on the way up: in Q3 they reduced realized oil by about $12 a barrel and produced a $100 million total derivative loss, which is why GAAP earnings can swing from an $87 million profit in Q2 to a $2 million loss in Q3. Midstream access is the second risk; the Q2 2026 shut-ins and negative gas and NGL prices show how much a small producer depends on third-party pipes in New Mexico. Execution risk sits with the uncompleted well backlog and the untested San Andres plan at Red Lake. Scale matters too: at under $1 billion in market value, trading volume is thin (a few hundred thousand shares a day), so moves can be sharp. The Riley family and insiders hold a large stake, which aligns interests but limits the public float. Finally, a reduced 18-month hedging requirement gives management more room to leave barrels unhedged.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell AMPY or REPX; figures are approximate and dated (as of November 2026). Verify current data before investing.